A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC. The trial will use a unique adaptive clinical trial model backed by artificial intelligence to collect and analyze the data needed to help identify a possible therapy for COVID-19.
Read more about the trial here: https://www.upmc.com/media/news/040920-innovative-clinical-trials